Intralesional triamcinolone acetonide injection in hypertrophic skin surrounding the percutaneous titanium implant of a bone-anchored hearing aid.
OBJECTIVE
We present a patient with persistent hypertrophic skin surrounding the percutaneous implant of a bone-anchored hearing aid system, successfully treated with intralesional applied corticosteroids.


METHODS
Case report and review of the world literature concerning bone-anchored hearing aid implantation and intralesional applied corticosteroids for the treatment of hypertrophic scars and keloids.


RESULTS
Eight weeks after revision surgery to reduce surplus skin and subcutaneous scar tissue overgrowing the abutment, skin and subcutaneous scar tissue overgrowth reoccurred. As an alternative to yet another surgical procedure, the hypertrophic skin was treated with intralesional injections of triamcinolone acetonide. Three weeks after the treatment, a satisfying result was seen, and no subsequent relapse was observed.


CONCLUSIONS
To our knowledge, this is the first, photographically well documented case report of a patient with persistent hypertrophic skin surrounding a percutaneous bone-anchored hearing aid implant, successfully treated with intralesional applied corticosteroids.
Van Rijswijk
J B
JB
Department of Otorhinolaryngology, Head & Neck Surgery and Facial Plastics, Van Weel-Bethesda Hospital, Dirksland, The Netherlands. jeroen@vanryswyk.nl
Mylanus
E A M
EA
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D017439:Cicatrix, Hypertrophic / Q000188:drug therapy* / Q000601:surgery; D006310:Hearing Aids / Q000009:adverse effects*; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D016348:Osseointegration; D012008:Recurrence; D014025:Titanium; D016896:Treatment Outcome; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*
D000305:Adrenal Cortex Hormones; D014025:Titanium; D014222:Triamcinolone Acetonide